ANDA 88479, held by Heritage Pharma Avet. Thioridazine Hydrochloride.
As of Nov 16, 2026, ANDA 88479 (Thioridazine Hydrochloride), held by Heritage Pharma Avet, was first approved by FDA on Nov 8, 1983, with 10 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Nov 8, 1983 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Thioridazine Hydrochloride50MG · tablet;oral | Thioridazine Hydrochloride | Discontinued |
| Jan 22, 2025 | Supplement 18Labeling · Standard review | Approved | None posted |
| Feb 23, 2017 | Supplement 17Labeling · Standard review | Approved | None posted |
| Nov 3, 2015 | Supplement 16Labeling | Approved | None posted |
| Aug 7, 1991 | Supplement 12Manufacturing | Approved | None posted |
| Jan 28, 1991 | Supplement 13Manufacturing | Approved | None posted |
| Aug 9, 1990 | Supplement 14Labeling | Approved | None posted |
| Jun 29, 1990 | Supplement 6Manufacturing | Approved | None posted |
| Aug 10, 1989 | Supplement 9Bioequivalence | Approved | None posted |
| Aug 10, 1989 | Supplement 10Bioequivalence | Approved | None posted |
| Nov 15, 1984 | Supplement 2Manufacturing | Approved | None posted |
| Nov 8, 1983 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters